Corteva holds a commanding position in the agricultural inputs market with leading products in North America corn and soybeans, and major brands including Pioneer® and Brevant® that are synonymous with quality. The company plans to spin off its seeds business in 2026, transitioning to a pure-play crop protection company.
Cyborg Score Rationale
In 2025, Corteva showed 4% organic sales growth with operating EBITDA increasing 14% to $3.85 billion, while returning approximately $1.5 billion to shareholders through dividends and repurchases. The company projects operating EBITDA of $4.0-4.2 billion by end of 2026, marking 7% growth.
Top Insights
Corteva plans to split its seed and crop protection businesses by early 2027, introducing potential execution risks and higher costs.
Gene editing technology importance is emphasized, while a Bayer agreement is expected to enhance Corteva's competitive position in corn, cotton, and canola markets.
Rapid adoption of Enlist E3® soybean technology has made it the leading herbicide tolerance trait in the United States, underscoring innovation capability.
Corteva has factored in an estimated $80 million impact from global tariffs into its 2026 guidance across business operations.
Named Competitors
Crop Science — Leading integrated crop solutions and germplasm
Seeds & Crop Protection — Global agricultural biotechnology and chemical solutions
Nutrien — Crop nutrients and crop protection products
Recent Developments
(Feb 2026) Filed 10-K report revealing company at forefront of agricultural innovation
(Feb 2026) Q4 2025 EPS of $0.22 met expectations; revenue missed forecasts at $3.91B vs $4.24B
(Feb 2026) Full-year 2025 showed 4% organic sales growth with operating EBITDA up 14% to $3.85B
Open the full interactive Corteva, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.